#MedicalCannabis
#MedicalCannabis · page 2
- CBD Market
Will 2022 Be The Year When A Maturing European Cannabis Industry Becomes Mainstream?
FUELLED by last year’s significant progress the European cannabis industry is looking forward to further positive developments in 2022.
- CBD Market
Germany Needs Workable Adult-Use Legislation Capable Of Drying-Up The Illicit Market.
Leading German Cannabis Lawyer Kai-Friedrich Niermann reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are the main opportunities and challenges for the European cannabis industry in 2022 K-FN: The cannabis industry in Europe in its various sectors – medical, commercial hemp and CBD – has…
- News
French Biotech Start-up Secures Country’s First Medical Cannabis Research Licence
Biotech start-up Overseed has been awarded the first licence for agronomic and genetic research on cannabis in France by the National Agency for the Safety of Medicines and Health Products (ANSM).
- Opinion
26-Year-Old Dubliner Becomes Ireland’s First ‘Medical Cannabis Access Programme’ Patient
IRELAND now has its first patient through the state-approved Medical Cannabis Access Programme (MCAP) some four years after it was launched – but experts warn the scheme is still unfit for purpose.
- Press releases
Akanda Corp Closes $5m Private Placement
Akanda Corp has announced that it has closed a private placement for aggregate gross proceeds of $5,316,000.
- News
Irish Clinical Establishment Continues To Shun Cannabis Leaving Medical Access Programme Doomed to Failure
Drug policy specialist Natalie O’Regan on Ireland’s faltering Medical Cannabis Access Programme THE Medical Cannabis Access Programme (MCAP) was launched in 2017, four years later and the first product is now being made available for patients.
- Press releases
LYPHE Group Opens Registration To Patient Representative Board
IN an industry first, LYPHE is bringing patients to the table to explore how to improve the patient experience across the organisation – and the wider industry.
- Pharmaceutical
UK Cannabis Company’s C-Suite Left ‘Shaking Their Heads’ In Disbelief At Company’s Poor Stock Performance
FOLLOWING its listing on the London Stock Exchange in May this year Oxford Cannabinoid Technologies (OCT) has seen more than £20m wiped off its market capitalisation.
- Adult-Use
US Company Set To Launch UK Medical Cannabis Study In Partnership With Manchester University
A GROUND-BREAKING human pilot study centred on the University of Manchester could provide answers to using cannabis as a pain relief treatment.
- Adult-Use
‘Exciting Times’ in Germany As Leading Medical Cannabis Player Looks To Post-Election Adult-Use Market
Cansativa won the sole contract to distribute homegrown medical cannabis to the domestic market but will the move towards adult-use in Germany impact its business?
- Opinion
Why Precision-Fermented Cannabinoids Should Be The Chosen Path For The European Cannabis Industry
Precision-fermented cannabinoids are likely to disrupt Europe’s emerging medicinal and recreational cannabis-farming industry over the next few years – and that’s a very good thing, says Jim Plamondon.
- Medical
Did Luxembourg Really Just Pay 3 Million Euros For 30 Kilos Of Medical Cannabis?
BEING the richest country in the world seems to have some inherent advantages.
